Immunosuppressants Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunosuppressants stocks.

Immunosuppressants Stocks Recent News

Date Stock Title
Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Jul 3 ABBV Company News for Jul 3, 2024
Jul 3 ABBV AbbVie: A Hold Again (Rating Downgrade)
Jul 2 TEVA Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
Jul 2 BIIB Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Jul 2 BIIB US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
Jul 2 TEVA FTC investigates Teva over contested product patents
Jul 2 BIIB Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
Jul 2 CHRS Coherus out licenses Canadian rights to cancer drug Loqtorzi
Jul 2 BIIB Biogen Completes Acquisition of Human Immunology Biosciences
Jul 2 ABBV With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Jul 2 ABBV AbbVie to Host Second-Quarter 2024 Earnings Conference Call
Jul 1 TEVA Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings
Jul 1 TEVA Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity
Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Jul 1 TEVA Teva focus of FTC investigation over inhaler patents
Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
Immunosuppressants

Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.In general, deliberately induced immunosuppression is performed to prevent the body from rejecting an organ transplant. Additionally, it is used for treating graft-versus-host disease after a bone marrow transplant, or for the treatment of auto-immune diseases such as systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, or Crohn's disease. This is typically done using medications, but may involve surgery (splenectomy), plasmapheresis, or radiation. A person who is undergoing immunosuppression, or whose immune system is weak for some other reasons (chemotherapy or HIV), is said to be immunocompromised.

Browse All Tags